Rosuvastatin Slows Progression of Carotid Intima-Media Thickness: The METEOR-China Randomized Controlled Study.

Stroke · 2022 · PMC9508961 · PMID 36017704

Europe PMC DOI

hedged sentence

0.0730

closest p · 1.5× alpha

0.0730

boldest claim

The sentences

did not reach statistical significanceP =0.073so close (0.05 < p ≤ 0.1)

Rosuvastatin treatment also showed favorable effects on the annualized rate of change of the MeanMax CIMT of the carotid bulb and ICA sites, although the differences compared with placebo did not reach statistical significance (mean difference, −0.0162 mm/y [95% CI, −0.0339 to 0.0015]; P =0.073 and −0.0043 mm/y [95% CI, −0.0183 to 0.0097]; P =0.547, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.